Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Xenon Pharmaceuticals Inc. XENE

Full chart Compare
Set alert

Price alert · XENE

All alert types
37.68 USD -1.51 (-3.85%)

At closeNov 6, 2026, 6:10 AM EST

36.61 -1.07 -2.84%

Pre-market · Nov 6, 6:10 AM ET

37.59 Day range 39.34
33.38 52-week range 72.66
YTD
-15.93%
1 year
-1.62%

Financial health

Altman Z-Score

39.21 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -10.3×
FY 2016: -5.2×FY 2017: -1.7×FY 2018: -3.5×FY 2019: -8.5×FY 2020: -18.5×FY 2021: -17.6×FY 2022: -19.1×FY 2023: -16.9×FY 2024: -13.0×FY 2025: -10.3×
FY 2016 5y median -16.9× FY 2025
P/S 474×
FY 2016: 66.2×FY 2017: 164×FY 2018: 0.0×FY 2019: 49.8×FY 2020: 16.5×FY 2021: 73.9×FY 2022: 253×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 474×
FY 2016 5y median 73.9× FY 2025
P/B 6.1×
FY 2016: 1.9×FY 2017: 1.4×FY 2018: 1.2×FY 2019: 3.7×FY 2020: 3.1×FY 2021: 2.5×FY 2022: 3.3×FY 2023: 3.3×FY 2024: 4.0×FY 2025: 6.1×
FY 2016 5y median 3.3× FY 2025
P/FCF -12.7×
FY 2016: -6.0×FY 2017: -1.8×FY 2018: -3.5×FY 2019: -57.9×FY 2020: -10.5×FY 2021: -19.0×FY 2022: -23.6×FY 2023: -20.4×FY 2024: -16.6×FY 2025: -12.7×
FY 2016 5y median -19.0× FY 2025
EV/EBITDA -9.8×
FY 2016: -4.3×FY 2017: -1.2×FY 2018: -2.1×FY 2019: -8.3×FY 2020: -17.5×FY 2021: -15.3×FY 2022: -18.3×FY 2023: -14.0×FY 2024: -12.4×FY 2025: -9.8×
FY 2016 5y median -14.0× FY 2025
EV/Sales 448×
FY 2016: 56.7×FY 2017: 120×FY 2018: 0.0×FY 2019: 48.6×FY 2020: 15.2×FY 2021: 64.8×FY 2022: 248×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 448×
FY 2016 5y median 64.8× FY 2025
FCF Yield -7.9%
FY 2016: -16.6%FY 2017: -57.1%FY 2018: -28.7%FY 2019: -1.7%FY 2020: -9.6%FY 2021: -5.2%FY 2022: -4.2%FY 2023: -4.9%FY 2024: -6.0%FY 2025: -7.9%
FY 2016 5y median -5.2% FY 2025

Profitability

Gross Margin 66.1%
FY 2016: 38.2%FY 2017: -8122.8%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 66.1%
FY 2016 5y median 66.1% FY 2025
Operating Margin -4974.3%
FY 2016: -1376.4%FY 2017: -10474.3%FY 2018: 0.0%FY 2019: -627.0%FY 2020: -97.3%FY 2021: -428.4%FY 2022: -1368.9%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -4974.3%
FY 2016 5y median -428.4% FY 2025
Net Margin -4612.1%
FY 2016: -1275.5%FY 2017: -9872.7%FY 2018: 0.0%FY 2019: -609.1%FY 2020: -89.7%FY 2021: -427.8%FY 2022: -1328.9%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -4612.1%
FY 2016 5y median -427.8% FY 2025
ROE -59.5%
FY 2016: -36.0%FY 2017: -85.4%FY 2018: -33.4%FY 2019: -45.2%FY 2020: -16.8%FY 2021: -14.3%FY 2022: -17.4%FY 2023: -19.7%FY 2024: -31.0%FY 2025: -59.5%
FY 2016 5y median -19.7% FY 2025
ROIC -39.6%
FY 2016: -38.8%FY 2017: -76.2%FY 2018: -32.1%FY 2019: -39.2%FY 2020: -17.8%FY 2021: -14.1%FY 2022: -17.6%FY 2023: -22.8%FY 2024: -35.9%FY 2025: -39.6%
FY 2016 5y median -22.8% FY 2025
ROA -35.2%
FY 2016: -34.1%FY 2017: -66.6%FY 2018: -28.2%FY 2019: -28.2%FY 2020: -15.2%FY 2021: -13.8%FY 2022: -16.6%FY 2023: -18.9%FY 2024: -29.4%FY 2025: -35.2%
FY 2016 5y median -18.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -88.4%FY 2017: -82.8%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 371.0%FY 2021: -42.7%FY 2022: -48.8%FY 2023: -100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -33.6%
FY 2016: -165.1%FY 2017: -31.3%FY 2018: -16.7%FY 2019: -12.6%FY 2020: 26.9%FY 2021: -152.4%FY 2022: -63.5%FY 2023: -65.7%FY 2024: -30.5%FY 2025: -33.6%
FY 2016 FY 2025
EPS (diluted) -44.9%
FY 2016: -34.5%FY 2017: -15.5%FY 2018: -4.1%FY 2019: 13.5%FY 2020: 46.1%FY 2021: -113.3%FY 2022: -16.4%FY 2023: -32.5%FY 2024: -10.3%FY 2025: -44.9%
FY 2016 FY 2025
Free Cash Flow -51.7%
FY 2016: -6.4%FY 2017: -46.3%FY 2018: -21.3%FY 2019: 83.3%FY 2020: -764.5%FY 2021: -41.0%FY 2022: -41.6%FY 2023: -49.0%FY 2024: -22.2%FY 2025: -51.7%
FY 2016 FY 2025

Financial Health

Current Ratio 13.4×
FY 2016: 18.7×FY 2017: 11.0×FY 2018: 29.5×FY 2019: 3.3×FY 2020: 12.3×FY 2021: 39.0×FY 2022: 26.4×FY 2023: 23.6×FY 2024: 17.8×FY 2025: 13.4×
FY 2016 5y median 23.6× FY 2025
Quick Ratio 13.4×
FY 2016: 18.7×FY 2017: 11.0×FY 2018: 29.5×FY 2019: 3.3×FY 2020: 12.3×FY 2021: 39.0×FY 2022: 26.4×FY 2023: 23.6×FY 2024: 17.8×FY 2025: 13.4×
FY 2016 5y median 23.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2016: 0.7×FY 2017: 0.5×FY 2018: 1.6×FY 2019: 0.2×FY 2020: 1.5×FY 2021: 2.1×FY 2022: 0.4×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -27.3×FY 2019: -29.9×FY 2020: -64.7×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31